To reduce overdoses, and morbidity and deaths from overdoses
Expanding availability and access to overdose reversal products
Advancing development of novel overdose reversal products
Facilitating evidence-based use of fentanyl testing strips
United States Government Partners
Department of Health & Human Services (HHS)
National Institutes of Health (NIH)
Centers for Disease Control and Prevention (CDC)
Centers for Medicare & Medicaid Services (CMS)
Substance Abuse and Mental Health Services Administration (SAMHSA)
Indian Health Service (IHS)
FDA Activities
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
